Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
02:06pm, Tuesday, 11'th Oct 2022 Benzinga
Upgrades
According to Deutsche Bank, the prior rating for Scorpio Tankers Inc (NYSE:STNG) was changed from Sell to Hold. For the second quarter, Scorpio Tankers had an EPS of $3.13, compared to year-a
Big-Cap S&P Stocks Will Soon Provide Tech-Like Returns, I Explain
04:10am, Monday, 10'th Oct 2022 Seeking Alpha
Learn more about an opportunity to acquire well-known big-cap names in the S&P 500 that, at this point, could provide "tech-like" returns.
Biohaven Ltd. (BHVN) Surges 7.6%: Is This an Indication of Further Gains?
07:24am, Friday, 07'th Oct 2022 Zacks Investment Research
Biohaven Ltd. (BHVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down t
Seagen: A Stellar Portfolio Anchor
07:32pm, Tuesday, 04'th Oct 2022
As it successfully transitioned into a commercial-stage operator, Seagen is enjoying great progress. The four drugs powering Seagen's marketed portfolio are generating robust revenue growth.
Will Seagen's (SGEN) Portfolio of Drugs Help Combat Rivalry?
02:05pm, Tuesday, 04'th Oct 2022 Zacks Investment Research
Seagen (SGEN) expects its portfolio of marketed drugs, which are approved for various cancer indications, to generate incremental sales and combat stiff competition.
Will Seagen's (SGEN) Portfolio of Drugs Help Combat Rivalry?
11:17am, Tuesday, 04'th Oct 2022
Seagen (SGEN) expects its portfolio of marketed drugs, which are approved for various cancer indications, to generate incremental sales and combat stiff competition.
'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company
02:10pm, Friday, 30'th Sep 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock.
When asked about
Standalone Seagen Is Starting To Look Attractive
10:21am, Friday, 30'th Sep 2022
Seagen is now trading below the levels that implied a high probability of a buyout. Label expansion opportunities for approved products and the expanding pipeline will drive strong topline growth in t
Seagen: Upcoming Short- And Medium-Term Clinical Catalysts
04:13am, Friday, 30'th Sep 2022
Only one future study readout was talked about in Seagen's Q2 earnings call. However, six additional human trials are estimated to complete in the next 6 months.
Virtus' Joe Terranova offers his volatility playbook
05:22pm, Tuesday, 27'th Sep 2022
Joe Terranova, Virtus Investment Partners chief market strategist, joins 'Closing Bell: Overtime' to discuss CNBC's Alpha Survey results and where he's looking in the market now.
Seagen (SGEN) Inks Deal With LAVA Therapeutics for LAVA-1223
03:44pm, Tuesday, 27'th Sep 2022 Zacks Investment Research
Seagen (SGEN) signs an exclusive agreement with LAVA Therapeutics to develop and commercialize the latter's preclinical asset, LAVA-1223, targeting EGFR-expressing solid tumors.
Seagen (SGEN) Inks Deal With LAVA Therapeutics for LAVA-1223
12:47pm, Tuesday, 27'th Sep 2022
Seagen (SGEN) signs an exclusive agreement with LAVA Therapeutics to develop and commercialize the latter's preclinical asset, LAVA-1223, targeting EGFR-expressing solid tumors.
Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday
09:15am, Tuesday, 27'th Sep 2022 Benzinga
Gainers
LAVA Therapeutics N.V. (NASDAQ: LVTX) shares climbed 97.5% to close at $4.74 on Monday after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seage
Nasdaq Turns Lower; Crude Oil Drops Sharply
06:49pm, Monday, 26'th Sep 2022 Benzinga
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite turning negative on Monday.
The Dow traded down 1.02% to 29,287.62 while the NASDAQ fell 0.22% to 10,843.61. The S&P 500 a
Why LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session
06:05pm, Monday, 26'th Sep 2022 Benzinga
Gainers
LAVA Therapeutics N.V. (NASDAQ: LVTX) shares jumped 97% to $4.71 after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seagen will work to develop
